Results 41 to 50 of about 221,753 (302)

Factors associated with COVID-19 non-vaccination among children and adolescents with chronic health conditions in Canada: A national cross-sectional study

open access: yesVaccine: X
Background: COVID-19 vaccine rollout has prioritized high risk populations, including children with chronic health conditions (CHC), who are at greater risk of severe illness and hospitalization if infected.
Arlanna Pugh   +3 more
doaj   +1 more source

Determinants of influenza non-vaccination among Canadian children: insights from a nationwide survey

open access: yesFrontiers in Public Health
BackgroundTo identify determinants influencing Canadian parents’ decision not to vaccinate their children aged 6 months to 17 years against seasonal influenza.MethodsData from the 2022 Childhood COVID-19 Immunization Coverage Survey, a national survey of
Abdallah Alami   +5 more
doaj   +1 more source

Determinants of incomplete vaccination against polio by 2 years of age in Canada: A cross-sectional study using the Childhood National Immunization Coverage Survey (CNICS)

open access: yesVaccine: X
Background: Canada has not reached the national vaccination coverage goal of 95 % for polio vaccination in 2-year-old children. The objective of this study was to examine determinants of incomplete polio vaccination (receipt of less than 3 doses of a ...
Israa Zareef   +4 more
doaj   +1 more source

Determinants of vaccination coverage and consequences for rabies control in Bali, Indonesia [PDF]

open access: yes, 2017
Maintaining high vaccination coverage is key to successful rabies control, but mass dog vaccination can be challenging and population turnover erodes coverage.
Arief, Riana A.   +15 more
core   +2 more sources

National Near Real-Time Vaccine Effectiveness Against COVID-19 Severe Outcomes Using the Screening Method Among Older Adults Aged ≥50 Years in Canada

open access: yesVaccines
Background/Objectives: It is critical to monitor real-world COVID-19 vaccine effectiveness (VE) in older adults, as they have been identified as a priority group for vaccination.
Robert MacTavish   +10 more
doaj   +1 more source

Examining the Impact of Key Factors on COVID-19 Vaccination Coverage in India: A PLS-SEM Approach

open access: yesVaccines, 2023
During the coronavirus disease 2019 (COVID-19) pandemic, numerous factors determined the performance of COVID-19 vaccination coverage. The purpose of this study is to examine the influence of factors such as government stewardship, planning and ...
Veena Dhawan   +9 more
doaj   +1 more source

Factors associated with parental intentions to vaccinate 0-4-year-old children against COVID-19 in Canada: a cross-sectional study using the Childhood COVID-19 Immunization Coverage Survey (CCICS)

open access: yesBMC Public Health
Background The objective of this study was to determine the factors associated with low or no parental intention to vaccinate children of 0-4-years in Canada with a COVID-19 vaccine through the 2022 Childhood COVID-19 Immunization Coverage Survey (CCICS).
Israa Zareef   +7 more
doaj   +1 more source

Investigating the Marginal and Herd Effects of COVID-19 Vaccination for Reducing Case Fatality Rate: Evidence from the United States between March 2021 to January 2022

open access: yesVaccines, 2023
Vaccination campaigns have been rolled out in most countries to increase vaccination coverage and protect against case mortality during the ongoing pandemic.
Tenglong Li   +3 more
doaj   +1 more source

Self-enforcing regional vaccination agreements [PDF]

open access: yes, 2016
In a highly interconnected world, immunizing infections are a transboundary problem, and their control and elimination require international cooperation and coordination. In the absence of a global or regional body that can impose a universal vaccination
Grenfell, Bryan T.   +3 more
core   +1 more source

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy